The Path to Precision Medicine: From Discovery to Patient Care


Alan Shuldiner, MD

Vice President, Regeneron Genetics Center, Regeneron

Learning Objectives:

1. To describe the challenges of finding safe and effective therapeutic targets and the promise of applying human genetics to the challenge.
2. To describe the approaches of exome-wide and phenome-wide association analysis toward identifying novel therapeutic targets, unanticipated indications, and potential on-target side effects.
3. To describe how patient genomic information may be incorporated into clinical care toward the goal of precision medicine.

A live webcast sponsored by:

The Rockefeller University Hospital Center for Clinical and Translational Science and Clinical Directors Network, Inc. (CDN)


Wednesday, November 15th, 2017 12:00 PM – 1:00 PM EST


The Path to Precision Medicine: From Discovery to Patient Care (PDF)

This activity has been reviewed and approved for up to 1.0 Prescribed credit(s) by the American Academy of Family Physicians (AAFP). Enduring credits valid until November 15, 2018.

Recent Webcasts

Sex in the Time of COVID-19

Kenneth H. Mayer, M.D., Medical Research Director, Fenway Health, Co-Director, The Fenway Institute, Professor of Medicine, Harvard Medical School, Attending Physician, Infectious Disease...

Opioid Prescribing in the COVID-19 Era

Joanna L. Starrels, MD, MS, FACP, Associate Professor of Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Division of General Internal Medicine
Hector R. Perez,...

Prescription Pain Medication Use in the Community

Linda B. Cottler, PhD, MPH, FACE, Associate Dean for Research, College of Public Health and Health Professions and Dean's Professor of Epidemiology at the University of Florida